Education
About Us
Working with TipRanks
Follow Us
AXM Pharma (AXMP)
:AXMP
AXMP Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.10 - $0.10
Previous CloseN/A
Volume500.00
Average Volume (3M)6.18K
Market Cap
$40.86K
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta64.41
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding408,603,000
10 Day Avg. Volume18,533
30 Day Avg. Volume6,178
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
AXMP FAQ
What was AXM Pharma ’s price range in the past 12 months?
AXM Pharma lowest stock price was $0.10 and its highest was $0.10 in the past 12 months.
What is AXM Pharma ’s market cap?
AXM Pharma ’s market cap is $40.86K.
When is AXM Pharma ’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were AXM Pharma ’s earnings last quarter?
Currently, no data Available
Is AXM Pharma overvalued?
According to Wall Street analysts AXM Pharma ’s price is currently Overvalued.
Does AXM Pharma pay dividends?
AXM Pharma does not currently pay dividends.
What is AXM Pharma ’s EPS estimate?
AXM Pharma ’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does AXM Pharma have?
AXM Pharma has 408,603,000 shares outstanding.
What happened to AXM Pharma ’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of AXM Pharma ?
Currently, no hedge funds are holding shares in AXMP
Company Description
AXM Pharma
AXM Pharma, Inc. manufactures and sells over-the-counter and prescription pharmaceutical products in the People's Republic of China. The company is based in New York, New York.
Technical Analysis
Hepion Pharmaceuticals
―
Windtree Therapeutics
―
LogicMark
―
Universe Pharmaceuticals
―
Sharps Technology, Inc.
―